These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34261897)

  • 61. The liver in pediatric gastrointestinal disease.
    Vo HD; Xu J; Rabinowitz SS; Fisher SE; Schwarz SM
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):288-99. PubMed ID: 25144777
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
    Saich R; Chapman R
    World J Gastroenterol; 2008 Jan; 14(3):331-7. PubMed ID: 18200656
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Colitis-associated sclerosing cholangitis in children: a single centre experience.
    Noble-Jamieson G; Heuschkel RB; Torrente F; Hadzic N; Zilbauer M
    J Crohns Colitis; 2013 Nov; 7(10):e414-8. PubMed ID: 23485432
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recurrent nonviral liver disease following liver transplantation.
    Li KK; Neuberger J
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):257-68. PubMed ID: 19485808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
    van Munster KN; Bergquist A; Ponsioen CY
    J Hepatol; 2024 Jan; 80(1):155-168. PubMed ID: 37940453
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Disease progression in paediatric- and adult-onset sclerosing cholangitis: Results from two independent Dutch registries.
    Joosse ME; Haisma SM; Sterk MFM; van Munster KN; Ponsioen CIJ; Houwen RHJ; Koot BGP; de Meij T; van Rheenen PF; de Koning BAE
    Liver Int; 2019 Sep; 39(9):1768-1775. PubMed ID: 31152478
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease.
    Goyal A; Hyams JS; Lerer T; Leleiko NS; Otley AR; Griffiths AM; Rosh JR; Cabrera JM; Oliva-Hemker MM; Mack DR; Rick JN; Pfefferkorn MD; Carvalho R; Grossman AB; Hitch MC; Sudel B; Kappelman MD; Saeed SA; Faubion WA; Schaefer ME; Markowitz JF; Keljo DJ;
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):321-3. PubMed ID: 24796799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases.
    McNair AN; Moloney M; Portmann BC; Williams R; McFarlane IG
    Am J Gastroenterol; 1998 May; 93(5):777-84. PubMed ID: 9625127
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice.
    van Beers JJBC; Koek GH; Damoiseaux JGMC
    J Appl Lab Med; 2022 Jan; 7(1):259-267. PubMed ID: 34996079
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatobiliary associations with inflammatory bowel disease.
    Knight C; Murray KF
    Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):681-91. PubMed ID: 19929587
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Overlap syndrome: autoimmune sclerosing cholangitis.
    Thakker A; Karande S
    Indian Pediatr; 2010 Dec; 47(12):1063-5. PubMed ID: 21220805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Hepatobiliary manifestations in inflammatory bowel disease].
    Solís Herruzo JA; Solís-Muñoz P
    Rev Esp Enferm Dig; 2007 Sep; 99(9):525-42. PubMed ID: 18052648
    [No Abstract]   [Full Text] [Related]  

  • 76. Autoimmune hepatitis and primary sclerosing cholangitis.
    Alvarez F
    Clin Liver Dis; 2006 Feb; 10(1):89-107, vi. PubMed ID: 16376796
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Autoimmune hepatitis from the paediatric perspective.
    Roberts EA
    Liver Int; 2011 Nov; 31(10):1424-31. PubMed ID: 22093323
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Immune-mediated liver diseases].
    Pár A
    Orv Hetil; 2007 Apr; 148 Suppl 1():35-8. PubMed ID: 17430792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.